Search for: "GLOBAL BIOTECHNOLOGIES INC"
Results 121 - 140
of 152
Sort by Relevance
|
Sort by Date
15 Jan 2009, 6:49 am
., 1938- TITLE Understanding bioethics and the law : the promises and perils of the brave new world of biotechnology / Barry R. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission… [read post]
7 Nov 2008, 10:51 am
The U.S. and Europe have been expanding their production of medical products globally for several years because it is cheaper to do so. [read post]
7 Nov 2008, 3:42 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC affirms rejection of claim reciting broad genus of monoclonal antibodies for failure to satisfy written description requirement: In re Alonso… [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust… [read post]
19 Sep 2008, 6:00 pm
: (Wired) The South strikes back against overreaching IP enforcement: (Intellectual Property Watch) WIPO assembly set to appoint new head: (Managing Intellectual Property) Open business systems fill gap in mainstream entertainment industry: (Intellectual Property Watch) Global - Trade Marks / Domain Names / Brands Brand values collapse in the face of global financial turmoil: (IAM), Genericness survey results: (Property, intangible) Reputation as risk: a lesson from the… [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2008, 1:50 am
: (Seattle Trademark Lawyer) Global - Patents Global science – threat to local innovation? [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP) Global - Copyright Audio books: is there a brave new world after DRM? [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
16 May 2008, 8:03 am
– Discussion of T Berg’s paper ‘IP and the preferential option for the poor’: (ISinIP), Patent valuation: differing analytical methods: (Hal Wegner) Global - Copyright Copyright as an engine of free expression? [read post]
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry),… [read post]
25 Apr 2008, 6:37 am
Another issue is (at least the perception) that the University is too risk-adverse: Deals must pass “the Chronicle test,” said Jack Newman, a UC Berkeley graduate and now senior vice president of research at Amyris Biotechnologies Inc. in Emeryville. [read post]
11 Apr 2008, 9:00 am
: (Innovationpartners) Global - Patents Discussion of Bessen and Meurer’s book ‘Patent Failure’: (IPBiz), IP at AE Biofuels for ethanol: (IPBiz), WIPO circulates links to amended PCT Regulations to take effect 1 July: (IPKat), Procedure to kill a patent in the battlefield: (ezine@rticles) Global - Copyright International whisper campaign against fair use: (Techdirt) Events 24th Sitka Symposium: ‘Gifts of… [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four… [read post]
